Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New treatment options improve outlook for patients with viral skin infections

Dec. 3, 1996

New anxiolytic under development at Parke-Davis

Dec. 2, 1996

Antiepileptic agent reported by Parke-Davis

Dec. 2, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

RESTORE trial results presented at AHA meeting

Nov. 22, 1996

ACE inhibitor-AT antagonist combination therapy results presented at AHA congress

Nov. 22, 1996

Calcium channel blocker update

Nov. 22, 1996

Pfizer's antiasthma drug R&D

Nov. 20, 1996

Latest findings on the diagnosis and treatment of erectile dysfunction

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 20, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...